Better Medicine, Together
Most trusted partner in therapeutic drug discovery with fully integrated services and cutting-edge platform technologies across multiple modalities
Empowering Drug Discovery through expertise and integrated solutions
We help our ecosystem of partners and collaborators discover drugs by providing fully integrated services and offering access to foundational technologies. We specialize in multiple modalities and take on challenging projects with confidence, backed by our years of experience and track record of success.
Antibodies & Bispecifics
End-to-end discovery services and proprietary platforms
Our platforms and fully integrated services streamline the path to IND for your monoclonal and bispecific programs. We offer cutting-edge in vivo discovery platforms combined with end-to-end services across monoclonal discovery, bispecific engineering, and lead optimization to quickly and efficiently deliver high-quality, de-risked therapeutic candidates.
TCR Mimics
Unlock new targets with TCRms
TCRm antibodies mimic the function of T-cell receptors by targeting intracellular peptides presented on cell surface MHC complexes (pMHC), opening up a wide range of intracellular targets in oncology and infectious disease. Keyway™ TCRm discovery is the first fully integrated platform and service, combining our world-class antibody discovery expertise with the pioneers of TCR Therapeutics.
Genetic medicines
Empowering breakthroughs with Alloy’s antisense platform
Alloy Therapeutics offers foundational technologies and discovery capabilities that address the therapeutic index and delivery challenges that have historically limited the promise of ASO drug candidates. Collaborate with us to transform your existing sequences or discover de novo molecules in our proprietary Anticlastic™ antisense format, a transiently cyclized structure designed for improved potency, safety, and scalability.
Collaboration among scientists, competition against disease
We collaborate with our partners to leverage the full potential of our technology and services, acting as an innovation engine for the drug discovery industry.
